These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21042052)

  • 1. The last decade of microbicide clinical trials in Africa: from hypothesis to facts.
    Ramjee G; Kamali A; McCormack S
    AIDS; 2010 Oct; 24 Suppl 4():S40-9. PubMed ID: 21042052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ; Uckun FM
    Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical microbicides for prevention of sexually transmitted infections.
    Obiero J; Mwethera PG; Wiysonge CS
    Cochrane Database Syst Rev; 2012 Jun; (6):CD007961. PubMed ID: 22696373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis.
    Obiero J; Mwethera PG; Hussey GD; Wiysonge CS
    BMC Infect Dis; 2012 Nov; 12():289. PubMed ID: 23130761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned.
    Friend DR; Kiser PF
    Antiviral Res; 2013 Sep; 99(3):391-400. PubMed ID: 23845918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
    Doggett EG; Lanham M; Wilcher R; Gafos M; Karim QA; Heise L
    J Int AIDS Soc; 2015; 18(1):20536. PubMed ID: 26700845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on microbicide research and development - seeking new HIV prevention tools for women.
    Mertenskoetter T; Kaptur PE
    Eur J Med Res; 2011 Jan; 16(1):1-6. PubMed ID: 21345763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hidden heterogeneity: Uncovering patterns of adherence in microbicide trials for HIV prevention.
    Miller L; Prieto Merino D; Baisley K; Hayes R
    PLoS One; 2022; 17(5):e0267011. PubMed ID: 35551324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of vaginal microbicides in preventing HIV transmission.
    Musekiwa A; Fernando NB; Abariga SA
    Trop Med Int Health; 2020 Jul; 25(7):790-802. PubMed ID: 32306503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbicides: putting women in control.
    Forbes A
    WORLD; 1998 Sep; (89):4-5. PubMed ID: 11365770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twice-daily application of HIV microbicides alter the vaginal microbiota.
    Ravel J; Gajer P; Fu L; Mauck CK; Koenig SS; Sakamoto J; Motsinger-Reif AA; Doncel GF; Zeichner SL
    mBio; 2012 Dec; 3(6):. PubMed ID: 23249810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbicide clinical trial adherence: insights for introduction.
    Woodsong C; MacQueen K; Amico KR; Friedland B; Gafos M; Mansoor L; Tolley E; McCormack S
    J Int AIDS Soc; 2013 Apr; 16(1):18505. PubMed ID: 23561044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbicides and HIV prevention: lessons from the past, looking to the future.
    Morris GC; Lacey CJ
    Curr Opin Infect Dis; 2010 Feb; 23(1):57-63. PubMed ID: 19918175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial prevention of HIV transmission in women: the case for a vaginal microbicide.
    Bélec L; Jenabian MA; Charpentier C; Saïdi H
    Future Microbiol; 2011 Jul; 6(7):731-7. PubMed ID: 21797688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
    Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should microbicides be controlled by women or by physicians?
    Piret J; Bergeron MG
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e14-7. PubMed ID: 20932483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal microbicides and the prevention of HIV transmission.
    Cutler B; Justman J
    Lancet Infect Dis; 2008 Nov; 8(11):685-97. PubMed ID: 18992405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific microbicides in the prevention of HIV infection.
    Kelly CG; Shattock RJ
    J Intern Med; 2011 Dec; 270(6):509-19. PubMed ID: 21917029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbicides for the prevention of sexually transmitted HIV infection.
    Karim QA; Baxter C
    Expert Rev Anti Infect Ther; 2013 Jan; 11(1):13-23. PubMed ID: 23428099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbicides for HIV prevention.
    Ramjee G
    Indian J Med Res; 2011 Dec; 134(6):930-8. PubMed ID: 22310825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.